News

Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis and Sanofi will sell medicines at a discounted price on TrumpRx.

The proposed class action lawsuit against the San Diego-based health system alleges that a patient's medical visit was recorded using Abridge without his consent, violating California privacy laws.

Executives weigh in on current valuations and hype around AI in the healthcare sector and what it could mean for the future.

Virtual pediatric care company Clarity Pediatrics garners $14.5 million to expand into obesity care.

A handful of transformative transactions lifted 2025 merger and acquisitions totals, but dealmakers largely remained disciplined, prioritizing data-driven growth and digital platforms.

The company will use the funds to accelerate commercialization of its brain-signal AI technology and expand its cognitive health applications.

Next year, AI will move beyond administrative support to become a workflow-integrated tool that drives predictive and proactive care and sees true adoption, according to healthcare leaders.

Also, University of Queensland research has found ultrasound to be a safe approach to possibly treat symptoms of Alzheimer's disease in a world's first in-human trial.

Next year will mark a turning point for AI in healthcare as the industry shifts from pilots and hype to accountable, integrated systems that prove to have measurable impact, according to execs.

The microbiome-based test carries US FDA Breakthrough Device status and is designed to rule out low-risk autism cases early with over 95% negative predictive value.